Kingsview Wealth Management, LLC Incyte Corp Transaction History

Kingsview Wealth Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $381,582 - $477,744	5,680 New	5,680 $456,000
Q2 2022 Aug 16, 2022	SELL	$66.18 - $83.18 $71,937 - $90,416	-1,087 Reduced 28.64%	2,709 $206,000
Q1 2022 Feb 08, 2024	BUY	$66.02 - $79.71 $177,527 - $214,340	2,689 New	2,689 $213,000
Q4 2021 Feb 17, 2022	BUY	$63.34 - $74.11 $43,071 - $50,394	680 Added 21.82%	3,796 $279,000
Q3 2021 Dec 03, 2021	SELL	$68.67 - $84.02 $3,433 - $4,201	-50 Reduced 1.58%	3,116 $214,000
Q2 2021 Aug 17, 2021	SELL	$79.87 - $87.53 $23,961 - $26,259	-300 Reduced 8.66%	3,166 $266,000
Q1 2021 May 24, 2021	SELL	$76.02 - $100.5 $28,507 - $37,687	-375 Reduced 9.76%	3,466 $288,000
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $2,422 - $2,931	-30 Reduced 0.77%	3,841 $334,000
Q3 2020 Nov 19, 2020	BUY	$85.07 - $109.69 $33,687 - $43,437	396 Added 11.4%	3,871 $347,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $14,836 - $21,786	-200 Reduced 5.44%	3,475 $361,000
Q1 2020 May 11, 2020	SELL	$63.18 - $85.97 $631 - $859	-10 Reduced 0.27%	3,675 $269,000
Q4 2019 Jan 31, 2020	BUY	$73.04 - $95.72 $269,152 - $352,728	3,685 New	3,685 $322,000
Q4 2019 Jan 30, 2020	SELL	$73.04 - $95.72 $269,152 - $352,728	-3,685 Closed	0 $0
Q3 2019 Jan 29, 2020	SELL	$72.82 - $86.52 $10,922 - $12,978	-150 Reduced 3.91%	3,685 $274,000
Q2 2019 Jan 29, 2020	BUY	$73.52 - $88.7 $3,676 - $4,435	50 Added 1.32%	3,835 $326,000
Q1 2019 Jan 29, 2020	BUY	$63.56 - $88.17 $240,574 - $333,723	3,785 New	3,785 $326,000

652

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.